7674749

Source:http://linkedlifedata.com/resource/pubmed/id/7674749

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011750, umls-concept:C0087111
pubmed:issue	8978
pubmed:dateCreated	1995-10-19
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents, http://linkedlifedata.com/resource/pubmed/chemical/Rifampin
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0140-6736
pubmed:author	pubmed-author:MwingaAA
pubmed:issnType	Print
pubmed:day	23
pubmed:volume	346
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	812-3
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:7674749-Antitubercular Agents, pubmed-meshheading:7674749-Developing Countries, pubmed-meshheading:7674749-Drug Delivery Systems, pubmed-meshheading:7674749-Drug Monitoring, pubmed-meshheading:7674749-Health Expenditures, pubmed-meshheading:7674749-Humans, pubmed-meshheading:7674749-Patient Compliance, pubmed-meshheading:7674749-Rifampin, pubmed-meshheading:7674749-Tuberculosis, Multidrug-Resistant, pubmed-meshheading:7674749-Tuberculosis, Pulmonary
pubmed:year	1995
pubmed:articleTitle	Treatment in developing countries.
pubmed:publicationType	News